According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -106,50ย โฌ. In 2021 the company made an earnings per share (EPS) of -7,45ย โฌ an increase over its 2020 EPS that were of -9,84ย โฌ.